Dermata Therapeutics Inc. (DRMA)

AI Score

Unlock

0.73

0.02 (2.82%)

At close: Apr 17, 2025, 3:55 PM

Dermata Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net Income	-12.29M	-11.27M	-9.82M	-8.69M	-7.79M	-7.33M	-8.04M	-9.06M	-9.61M	-10.49M	-9.78M	-8.38M	-7.9M	-5.75M	-4.63M	-4.12M	-3.24M	-2.84M	-2.24M	-1.42M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	322.00	322.00	322.00	322.00
Stock-Based Compensation	657.65K	756.3K	866.49K	978.06K	522.08K	614.5K	718.31K	848.71K	930.33K	1.2M	1.11M	958.24K	1.91M	1.42M	1.27M	1.16M	n/a	n/a	n/a	n/a
Other Working Capital	272.54K	433.47K	368.74K	-126.16K	494.35K	-362.06K	-388.38K	509.61K	-135.03K	769.59K	487.69K	-273.91K	-121.42K	-674.84K	-688.41K	-570.72K	-522.94K	-484.36K	57.7K	18.71K
Other Non-Cash Items	846.59K	975.06K	846.88K	978.06K	390.82K	483.24K	587.05K	402.45K	615.33K	883.16K	648.33K	701.83K	502.84K	-110.66K	-94.68K	-79.58K	-36.49K	88.29K	72.16K	56.98K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	207.51K	858.2K	1.2M	247K	863.68K	-371.34K	-559.41K	340.25K	-153.58K	483.47K	215.2K	-99.77K	289.55K	14.44K	-133.97K	-385.9K	-755.85K	-740.97K	47.38K	-15.2K
Operating Cash Flow	-11.16M	-9.4M	-7.75M	-7.46M	-6.41M	-7.09M	-7.88M	-7.88M	-8.83M	-8.81M	-8.46M	-7.53M	-5.69M	-4.43M	-3.59M	-3.43M	-4.03M	-3.49M	-2.12M	-1.38M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.01M	1.32M	2.69M	2.69M	1.68M	1.37M	n/a	n/a
Common Stock Repurchased	-828	-828	-863.42	-35.42	-75.42	-75.42	-40	-40	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	1.11K	168.00	-70K	34.00	227.00	4.27B	4.27B	4.27B	4.27B	287.00	87.00	n/a	570K	570K	588.75K	1.21M	636.6K	636.6K	617.85K	n/a
Financial Cash Flow	6.89M	8.91M	4.26M	3.43M	7.61M	4.27B	4.27B	4.28B	4.27B	4.28M	18.66M	14.39M	15.96M	16.28M	3.28M	4.14M	2.57M	2.25M	867.85K	n/a
Net Cash Flow	-4.28M	-487.73K	-3.49M	-4.03M	1.2M	-1.44M	-2.19M	575.8K	-4.56M	-4.54M	10.2M	6.86M	10.27M	11.85M	-309.5K	717.68K	-1.46M	-1.24M	-1.26M	-1.38M
Free Cash Flow	-11.16M	-9.4M	-7.75M	-7.46M	-6.41M	-7.09M	-7.88M	-7.88M	-8.83M	-8.81M	-8.46M	-7.53M	-5.69M	-4.43M	-3.59M	-3.43M	-4.03M	-3.49M	-2.12M	-1.38M